Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 2Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Lymphoma 1HTLV-I Infections 1

Interventions

pegylated granulocyte colony-stimulating factor 4entecavir 3Granulocyte Colony-Stimulating Factor 3Cyclophosphamide 3Brentuximab Vedotin 3Aprepitant 3Vinblastine 2Prednisolone 2Doxorubicin 2Dexamethasone 2rasburicase 1prednylidene 1plerixafor 1peginterferon alfa-2b 1pegfilgrastim 1golimumab 1fludarabine phosphate 1fludarabine 1fluarix 1ferrous succinate 1dexamethasone 21-phosphate 1arexvy 1abrysvo 1Zidovudine 1Water 1Watchful Waiting 1Vindesine 1Vincristine 1Valproic Acid 1Urate Oxidase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Lymphoma × Zidovudine × Clear all
NCT00854581 2018-04-17

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

University of Miami

Phase 4 Terminated
13 enrolled 15 charts
LymphoidOther hematologic neoplasmOther neoplasm

Lymphoma, Precancerous Conditions, HTLV-I Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡